
    
      Evaluation of safety and tolerability of the administration of ARCO and Eurartesim in terms
      of blood biochemistry, full blood count, ECG assessments, vital signs and adverse events
      profile in patients with uncomplicated P. falciparum malaria. Dihydroartemisinin/piperaquine
      will be used as comparator.
    
  